MetaCap

CAMP4 Therapeutics Statistics

NASDAQ: CAMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.79-0.21 (-5.25%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CAMP4 Therapeutics by the numbers

CAMP4 Therapeutics has a market capitalization of $237.8 million based on 62.75M shares outstanding. With trailing EPS of $-2.11, CAMP4 Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.8% below its 50-day average and 9.9% below its 200-day average.

Average daily trading volume is 238.88K shares, or about $905,340 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CAMP valuation vs. peer median

CAMP compared with the median of 8 peer companies
MetricCAMPPeer medianDifference
Market cap$237.84M$232.20M+2%
Avg. volume238.88K423.72K-44%

Peer median across 8 companies: LFCR, TTRX, QTTB, ENTA, IMRX, RCKT, KROS, PRLD.

Valuation

Market cap
$237.84M
Price / sales (latest FY)
67.99
EPS (TTM)
$-2.11

Price and trading

Previous close
4.00
Open
3.95
Day range
3.78 – 4.00
52-week range
2.90 – 7.75
52-week change
+30.69%
Beta
—
Volume
88.48K

Dividends and events

Annual dividend
None
Next earnings date
Aug 12, 2025

Additional statistics

Market Cap
237.84M
Forward Pe
-4.49
Eps
-2.11
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
7.75
Week52 Low
2.90
Avg Volume
238.88K
Shares Outstanding
62.75M
Ma50
3.82
Ma200
4.21
Earnings Date
Aug 12, 2025
Pct From52w High
-51.10%
Pct From52w Low
30.69%

Related